Solventum Corporation NYQ · SOLV

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire Inc. · 16d ago

3M vs. United Parcel Service: One of These Industrial Stocks Is a Much Better Buy Right Now

The Motley Fool · 94d ago

Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue

The Motley Fool · 129d ago

Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity

Investing.com · 228d ago

Solventum (SOLV) Q3 2025 Earnings Call Transcript

The Motley Fool · 253d ago

Up 30% This Year and With Plenty of Room to Run, This Blue Chip Stock Is a Value Investor's Dream

The Motley Fool · 258d ago

MediWound Revenue Jumps 43% in Q2

The Motley Fool · 338d ago

Solventum (SOLV) Fiscal Q2 EPS Jumps 8%

The Motley Fool · 345d ago

Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What’s Fueling the Surge? | MarketsandMarkets™.

GlobeNewswire Inc. · 353d ago

Is 3M Stock a Buy Now?

The Motley Fool · 504d ago

Solventum: Q4 EPS Beats, Cash Flow Dips

The Motley Fool · 505d ago

Trian Comments on Solventum’s Sale of its Purification & Filtration Business

GlobeNewswire Inc. · 507d ago

Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion

Benzinga · 508d ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

GlobeNewswire Inc. · 521d ago

3M Stock: Buy, Sell, or Hold?

The Motley Fool · 529d ago

Where Will 3M Stock Be in 3 Years?

The Motley Fool · 551d ago

Solventum Shares May Gain on the Launch of Its New V.A.C Therapy

Benzinga · 674d ago

Key Takeaways From Solventum Analyst Ratings

Benzinga · 753d ago

Avoid These Mistakes And Boost Your Portfolio's Income!

Seeking Alpha · 762d ago

Here's Why 3M's Dividend Reset Should Turn Off Most Income Investors

The Motley Fool · 777d ago

Results of the Ordinary and Extraordinary Shareholders' Meetings 2024

GlobeNewswire Inc. · 780d ago

Is 3M Spinoff Solventum a Buy? (And What It Means for 3M Investors)

The Motley Fool · 793d ago

This Ultra-High-Yield Dividend Stock Is About to Lose Its Crown

The Motley Fool · 807d ago

3M Stock Has 20% Upside, According to 1 Wall Street Analyst

The Motley Fool · 820d ago

How's AT&T Handling Things?

The Motley Fool · 830d ago